Artificial Intelligence for General and Rare Disease Diagnosis

StatusCompleted
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Completed without a posted recruiting period Show 9 more changesShow less
    • Final enrollment: 243 participants (planned 150)
    • Primary completion date changed from estimate of Dec 1, 2026 to Aug 19, 2026
    • Study sites: 13 to 11
    • Start date changed from estimate of Jun 20, 2026 to Jun 10, 2026
    • Secondary endpoints: 6 to 12
    • Study description expanded, about 8 words
    • Collaborators: 9 to 11
    • Eligibility criteria expanded, about 4 words
    • Study title expanded, about 2 words
  2. Study First Submitted
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A multicentre, randomised diagnostic accuracy study to evaluate whether the GENESIS AI diagnostic support system can improve diagnostic accuracy and efficiency for physicians managing real-world clinical general and rare cases.
Trial Details
NCT Number NCT07625436
Lead Sponsor Peking Union Medical College Hospital
Collaborators: Cangzhou Central Hospital, Zhangzhou Municipal Hospital of Fujian Province, Dongguan People's Hospital, First People's Hospital of Foshan, Tibet Autonomous Region People's Hospital, Guizhou Provincial People's Hospital, The First People's Hospital of Yunnan, Qinghai People's Hospital, Tianshui 407 Hospital, Wuhai People's Hospital, Fuping County Maternal and Child Hospital
Conditions
(from sponsor)		 Rare Disorders, Rare Diseases, Generalist AI
Related terms Disease, Rare Diseases
Enrollment 243 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov